0001296743-14-000002.txt : 20141120 0001296743-14-000002.hdr.sgml : 20141120 20141119202608 ACCESSION NUMBER: 0001296743-14-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141120 DATE AS OF CHANGE: 20141119 EFFECTIVENESS DATE: 20141120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EIGER BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454815 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-158936 FILM NUMBER: 141237288 BUSINESS ADDRESS: STREET 1: 1130 WELCH ROAD STREET 2: SUITE 336 CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-497-0184 MAIL ADDRESS: STREET 1: 1130 WELCH ROAD STREET 2: SUITE 336 CITY: PALO ALTO STATE: CA ZIP: 94304 D/A 1 primary_doc.xml X0707 D/A LIVE 0001454815 EIGER BIOPHARMACEUTICALS INC 1115 Lafayette St. Santa Clara CA CALIFORNIA 95050 415-203-0934 DELAWARE None None Corporation true David Cory 1115 Lafayette St. Santa Clara CA CALIFORNIA 95050 Executive Officer Director Ed Engleman 1115 Lafayette St. Santa Clara CA CALIFORNIA 95050 Director Jeffrey Glenn 1115 Lafayette St. Santa Clara CA CALIFORNIA 95050 Director Nina Kjellson 1115 Lafayette St. Santa Clara CA CALIFORNIA 95050 Director Biotechnology Decline to Disclose 06b true 0001454815-14-000002 2011-04-15 false true true Sale and issuance of Series A-1 Preferred Stock and the underlying Common Stock issuable upon conversion thereof. false 0 7257161 7240631 16530 false 8 0 0 0 false EIGER BIOPHARMACEUTICALS INC /s/ David Cory David Cory President and CEO 2014-11-19